Getagraph.com logo
S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

Sanntidsoppdatering for Pulmonx Corporation [LUNG]

Børs: NASDAQ Sektor: Healthcare Industri: Medical Devices
Upcoming Earnings Alert

3 days till quarter result
(bmo 2024-05-07)

Expected move: +/- 6.23%

BUY
100.00%
return 2.50%
SELL
0.00%
return 4.26%
Sist oppdatert3 mai 2024 @ 22:00
25% discount on Stockinvest.us - Use code: Podcast

4.69% $ 9.82

SELG 115646 min ago

@ $14.55

Utstedt: 14 feb 2024 @ 15:30

Avkastning: -32.51%

Forrige signal: feb 13 - 15:30

Forrige signal: Kjøp

Avkastning: 2.50 %

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):
Profile picture for Pulmonx Corporation

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation...

Stats
Dagens volum 705 914
Gjennomsnittsvolum 611 808
Markedsverdi 378.44M
EPS $0 ( 2024-02-21 )
Neste inntjeningsdato ( $-0.430 ) 2024-05-07
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -6.14
ATR14 $0.0140 (0.14%)
Insider Trading
Date Person Action Amount type
2024-04-22 Rose Geoffrey Beran Sell 1 184 Common Stock
2024-04-03 Joshi Mehul Buy 0
2024-03-22 Rose Geoffrey Beran Sell 1 184 Common Stock
2024-03-15 Williamson Steven S. Buy 425 116 Employee Stock Option (right to buy)
2024-03-15 Williamson Steven S. Buy 205 286 Common Stock
INSIDER POWER
77.50
Last 98 transactions
Buy: 1 710 475 | Sell: 224 988

Volum Korrelasjon

Lang: 0.39 (neutral)
Kort: 0.21 (neutral)
Signal:(66.486) Neutral

Pulmonx Corporation Korrelasjon

10 Mest positive korrelasjoner
DBX0.952
AKAM0.944
MFIN0.932
RAPT0.927
HILS0.92
BNIXU0.919
PEAR0.918
BRQS0.917
QDEL0.915
SMSI0.914
10 Mest negative korrelasjoner
BWC-0.959
ICON-0.952
LMNL-0.948
TWNK-0.944
SCR-0.941
IINN-0.936
PAE-0.928
FANG-0.927
NXGN-0.926
SCPL-0.926

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Pulmonx Corporation Korrelasjon - Valuta/Råvare

The country flag -0.13
( neutral )
The country flag -0.20
( neutral )
The country flag 0.00
( neutral )
The country flag -0.01
( neutral )
The country flag 0.24
( neutral )
The country flag -0.24
( neutral )

Pulmonx Corporation Økonomi

Annual 2023
Omsetning: $68.68M
Bruttogevinst: $50.35M (73.32 %)
EPS: $-1.600
FY 2023
Omsetning: $68.68M
Bruttogevinst: $50.35M (73.32 %)
EPS: $-1.600
FY 2022
Omsetning: $53.66M
Bruttogevinst: $39.87M (74.29 %)
EPS: $-1.590
FY 2021
Omsetning: $48.42M
Bruttogevinst: $35.63M (73.59 %)
EPS: $-1.350

Financial Reports:

No articles found.

Pulmonx Corporation

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.